WO2011121515A1 - Spray-dried crystalline active ingredient - Google Patents

Spray-dried crystalline active ingredient Download PDF

Info

Publication number
WO2011121515A1
WO2011121515A1 PCT/IB2011/051294 IB2011051294W WO2011121515A1 WO 2011121515 A1 WO2011121515 A1 WO 2011121515A1 IB 2011051294 W IB2011051294 W IB 2011051294W WO 2011121515 A1 WO2011121515 A1 WO 2011121515A1
Authority
WO
WIPO (PCT)
Prior art keywords
active ingredient
spray
process according
starch
drying
Prior art date
Application number
PCT/IB2011/051294
Other languages
French (fr)
Inventor
Christopher M. Gregson
Ronald H. Skiff
Ferdinand M. Triolo
Original Assignee
Firmenich Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Firmenich Sa filed Critical Firmenich Sa
Priority to BR112012024464-7A priority Critical patent/BR112012024464B1/en
Priority to JP2013502007A priority patent/JP5602936B2/en
Priority to EP11716063.0A priority patent/EP2552234B1/en
Priority to MX2012010555A priority patent/MX2012010555A/en
Priority to RU2012145868/13A priority patent/RU2539855C2/en
Priority to US13/637,214 priority patent/US20130028976A1/en
Priority to CN2011800146455A priority patent/CN102802436A/en
Publication of WO2011121515A1 publication Critical patent/WO2011121515A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
    • A23L27/72—Encapsulation
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Definitions

  • the present invention relates to a process for preparing a product comprising a crystalline active ingredient in water having excellent dissolution kinetics.
  • the invention also relates to a product produced according to the process.
  • the active material dissolves rapidly in an aqueous medium.
  • powdered beverages are diluted with water and consumed immediately, thus requiring all the ingredients to be dissolved rapidly so that the beverage has a balanced flavor.
  • the active ingredient dissolves sufficiently rapidly.
  • Such approaches include particle size reduction, modification of the crystal habit, dispersion in carriers, complexation and solubilization by surfactants.
  • WO-A-2008/006712 discloses a process for making contra-soluble nano-dispersions of at most sparingly-soluble materials in a soluble carrier material comprising the steps of:
  • drying is typically performed by spray-drying.
  • the present invention seeks to address one or more of the abovementioned problems and/or to provide one or more of the abovementioned benefits.
  • the present invention provides a process for preparing a spray- dried product for improving the rate of dissolution of the active ingredient, the process comprising the steps of:
  • the invention further provides spray dried particles prepared according to the above mentioned process.
  • the present invention relates to a process by which the dissolution kinetics of a crystalline active ingredient can be significantly improved.
  • the invention is based on the combination of certain components, such as compounds or ingredients, together with defined processing conditions.
  • the first critical component is a starch derivative.
  • starch derivative it is meant a chemically modified starch, more preferably a hydrophobically modified starch, even more preferably an alkenyl-succinated starch.
  • the alkenyl-succinated starch preferably has a degree of substitution of from 0.001 to 0.9.
  • the degree of substitution denotes the number of alkenylsuccinic functional groups per glucose units.
  • a degree of substitution of 0.001 means that there is 1 alkenylsuccinic functional group per 1000 glucose units.
  • the degree of substitution is more preferably from 0.005 to 0.3 and most preferably from 0.01 to 0.1, e.g. from 0.015 to 0.05.
  • the alkenyl-succinated starch is preferably a C3 to C14 alkenyl-succinated starch, more preferably C4 to C12, most preferably C5 to CIO, e.g. C7 to C9.
  • the alkenyl-succinated starch is octenyl-succinated starch.
  • the octenyl-succinated starch has a degree of substitution no greater than 0.03, more preferably no greater than 0.02.
  • the dissolution kinetics of the spray dried active ingredient are found to be significantly improved when the starch derivative is present in an amount of from 7% to 25% by weight, more preferably from 7 to 20%, based on the total weight of the mixture prior to spray-drying. At a level of less than 7%, the dissolution rate of the spray-dried active ingredient is hardly improved. Whereas, in an amount greater than 25%, the rate of dissolution is severely adversely affected. Without wishing to be bound by theory, it is believed that the reduction in the rate of dissolution is due to the insolubility of an excess of the starch derivative in water.
  • the second carrier material is preferably a carbohydrate.
  • the second carrier material may comprise monosaccharides, disaccharides, trisaccharides, oligosaccharides, polysaccharides or mixtures thereof.
  • Suitable monosaccharides include: D-Apiose, L-Arabinose, 2-Deoxy-D-ribose, D-Lyxose, 2-O-Methyl-D-xylose, D-Ribose, D-Xylose, which are all pentoses; and Hexoses, such as for instance, L-Fructose, L-galactose, D-Galactose, D-Glucose, D-Mannose, L-Rhamnose, L-Mannose; and mixture of two or more of these.
  • Mono- and dissacharides may be reduced to the corresponding alcohols, such as for example, xylitol, sorbitol, D-mannitol and/or maltitol.
  • alcohols such as for example, xylitol, sorbitol, D-mannitol and/or maltitol.
  • oxidation to aldonic, dicaroxyclic acids or uronic acids and reactions with acids, alkalis or amino compounds can give rise to many other compounds like isomaltol, for instance, which may comprise the second carrier material of the present invention.
  • Suitable oligosaccharides are molecules consisting of from 3 to 10 monosaccharide units, such as maltopentaose, fructo- and/or galacto-oligosaccharides.
  • the second carrier material comprises a maltodextrin, most preferably having a mean dextrose equivalence of 5 to 25, preferably 6 to 20, more preferably 10 to 19.
  • the second carrier material is present in an amount of from 40 to 80%, more preferably 60 to 80% by weight, based on the total weight of the mixture prior to spray-drying.
  • xanthan gum is a polysaccharide used as a food additive and rheology modifier. It is produced by fermentation of glucose or sucrose by the Xanthomonas campestris bacterium.
  • Xanthan gum is preferably added as a processing aid in order to maintain the insoluble crystalline solid suspended in solution prior to spray drying.
  • the optimum use level for maintaining an adequate suspension was found to be when the xanthan gum is present in an amount of from 0.3% to 0.6% by weight, based on the total weight of the mixture prior to spray-drying. In amounts inferior to 0.3%, it is a noticeable problem that the insoluble solids do not remain suspended in the slurry. Whereas, in amounts superior to 0.6%, the viscosity of the slurry is too high and this can adversely affect the homogenization step.
  • the active ingredient that is encapsulated is a compound that preferably has a dissolution rate in unstirred water at 25°C of more than 15 minutes at a concentration of 14 ppm.
  • dissolution rate is measured according to the method set out in the examples, described below.
  • the active ingredient is crystalline.
  • crystalline it is meant that the active ingredient forms a structure that exhibits long-range order in three dimensions. Crystallinity can be measured using known techniques in the art such as powder x-ray diffraction (PXRD) crystallography, solid state NMR, or thermal techniques such as differential scanning calorimetry (DSC).
  • PXRD powder x-ray diffraction
  • DSC differential scanning calorimetry
  • the active ingredient may also be a "sparingly water-soluble organic active agent" .
  • Such an ingredient is typically a compound that has a solubility in water of less than 5% by weight, preferably less than 1% by weight, more preferably less than 0.1% by weight, even more preferably less than 0.01% by weight, in water at 20°C.
  • Suitable active ingredients include those for use in the foodstuff, pharmaceutical and cosmetic applications.
  • a non-limiting list of examples includes: flavour and fragrance materials of both natural and synthetic origins, compounds and mixtures such as heliotropine, bromelia, (5RS,6RS)-2,6,10,10-tetramethyl-l-oxaspiro-[4,5]dec-6-yl acetate, acetanisole, methylsalicylique aldehyde, para-ethyl phenol, phenol, phenylethyl salicylate, menthol, cyclohexanecarboxamide, veratraldehyde, xylenol, dodecanoic acid, thymol, heliotropyl acetate, methyl anisate, methylnaphtylketone, myristic acid, palmitic acid, dimethylphenol, dimethyl acrylic acid, coumarine, methyl cyclopentenolone, 7-methylcoumarin, phenyla
  • the active ingredient is preferably present in an amount of from 15 to 25% by weight, based on the total weight of the spray dried particle.
  • a suitable process for producing the spray-dried particles of the invention comprises a first step of forming a dispersion, suspension or solution of the starch and second carrier material. This may be performed by simple mixing of the components with water, preferably hot water at a temperature of 60°C to 80°C. Separately, a dispersion or solution is prepared of the active ingredient in a suitable solvent, such as propylene glycol. The two solutions are then mixed together.
  • a suitable solvent such as propylene glycol
  • the resulting mixture is homogenized according to defined processing parameters in order to provide a product having excellent dissolution kinetics.
  • the spray dried particles are prepared by a process in which a homogenization step occurs at a minimum pressure of 4000 psig, more preferably 5000 psig or more, most preferably 5500 psig or more prior to the spray drying step.
  • the homogenization step is preferably carried out in two or more complete passes in a standard homogenizer.
  • a two-stage homogenizer is suitable for this purpose.
  • the mixture is subjected to a spray-drying step.
  • the spray drying is preferably performed using nozzle atomization only.
  • the spray pressure is preferably from about 1500 to 2500 psig.
  • the inlet temperature is preferably from 180°C to 200°C.
  • the outlet temperature is preferably from 70°C to 100°C.
  • the spray dried particles can then be collected by any standard process. Optionally and preferably they are passed through a sieve, such as a 20 Mesh screen to obtain a more homogeneous particle size.
  • the spray dried particles provide a significantly improved dissolution rate in a
  • the dissolution rate in a 0.05% aqueous citric acid solution of the spray dried particles at 25°C is preferably less than 15 minutes at a concentration of 14 ppm of the active ingredient, more preferably less than 10 minutes, even more preferably less than 4 minutes, most preferably less than 2 minutes.
  • Samples according to the invention are denoted by a number and comparative examples by a letter.
  • calculation of the dissolution kinetics of the spray-dried active ingredient are performed as follows.
  • Detection was made using a fiber optic spectrometer, comprising a D2Lite deuterium tungsten light source, TR 600-10 transmission probes (10mm pathlength tip) and a S2000 spectrometer (World Precision Instruments/ Ocean Optics). Data was recorded using the Ocean Optics software OOIBase32. Acquisition rate was set at one measurement per second.
  • the spectrum of the fully dissolved active was initially determined in the appropriate solvent (water or citric acid aq.) to find an appropriate wavelength for measurements. An amount of the spray dried powder was used for each experiment resulting in an equivalent nominal concentration of 14ppm of the active ingredient. The ax at 324 nm was chosen as the signal wavelength. A second wavelength (400 nm) where no absorption by the active ingredient was detected was used to correct the signal for changes in baseline caused by particles, turbidity, etc.
  • the spray dried powders were weighed on a weighing paper and rapidly tipped into the dissolution vessel (Distek 2100B, 1 liter flask maintained at 25°C using a water- bath) containing deionized water as the solvent for one set of experiments, and 500 ppm citric acid in deionized water for a second set of experiments.
  • the contents were stirred using paddles at 200 rpm.
  • Experiments were run until there was no longer a noticeable increase in absorbance on a plot of absorbance versus log time. The results were normalized by dividing the absorbance at each data point with the maximum absorbance. The kinetics of dissolution were quantified by finding the time at which the normalized absorbance reached 0.95. These values are equivalent to the dissolution of 95% of the active ingredient.
  • compositions given in table 1 were prepared as follows.
  • the xanthan gum, maltodextrin and starch were added to the water that had been preheated to 70°C, and mixed until fully dissolved.
  • the active ingredient was added to the propylene glycol solution and mixed for 30 minutes. The two mixtures were then combined and mixing was continued for a further 30 minutes.
  • the mixture was then transferred to a high pressure homogenizer and homogenization was carried out in two passes at the pressures given in the following table.
  • the homogenized product was then spray dried under standard conditions at an inlet temperature of 171°C and an outlet temperature of 82°C.
  • the resulting spray-dried particles were collected as a yellow powder. All amounts are parts by weight.
  • the active ingredient alone had a dissolution rate of 1106 seconds in water at 25 C and of 437 seconds in 0.05% aqueous citric acid solution.
  • the spray dried systems comprising the active ingredient show a remarkable improvement in dissolution kinetics in all cases when the spray dried active ingredient was dissolved in a dilute aqueous citric acid solution and in most cases where the spray dried active ingredient was dissolved in water.

Abstract

A process for preparing a spray-dried product for improving the rate of dissolution of the active ingredient comprises the steps of (i) mixing a crystalline active ingredient, which has a dissolution rate in unstirred water at 25°C of greater than 15 minutes at a concentration of 14ppm of the active ingredient, with a starch derivative, a second carrier material, and optionally xanthan gum to form a suspension, dispersion or solution of the active ingredient, (ii) homogenizing the mixture at a pressure of at least 4000 psig (2.758 x 107Pa), and (iii) spray-drying the homogenized mixture, the spray- dried active ingredient having an increased dissolution rate in water compared to the unencapsulated active ingredient.

Description

SPRAY-DRIED CRYSTALLINE ACTIVE INGREDIENT Technical Field
The present invention relates to a process for preparing a product comprising a crystalline active ingredient in water having excellent dissolution kinetics. The invention also relates to a product produced according to the process.
Background and Prior Art
Many potentially useful active materials are insoluble or at best only sparingly soluble in water. This places significant limits on their usefulness or requires that they are used in combination with solvents which is almost always more expensive than water and which may have physiological incompatibilities or environmental negatives.
In addition, it is desirable for many applications that the active material dissolves rapidly in an aqueous medium. For instance, powdered beverages are diluted with water and consumed immediately, thus requiring all the ingredients to be dissolved rapidly so that the beverage has a balanced flavor. Thus, there is a need to ensure that the active ingredient dissolves sufficiently rapidly.
Various approaches have been taken to improve solubility of poorly soluble materials. A review of these approaches is given in the publication "Formulation approaches for orally administered poorly soluble drugs", Pinnamaneni S., Das N.G., Das
S.K., Pharmazie, 2002, 57, 291 to 300. Such approaches include particle size reduction, modification of the crystal habit, dispersion in carriers, complexation and solubilization by surfactants.
Another review, "Improvement of solubility and dissolution rate of poorly water- soluble salicylic acid by a spray-drying technique" Kawashima Y, Saito M, Takenaka H, J. Pharm. Pharmacol. 1975, 27, 1-5 discloses spray drying a dispersion of salicylic acid in acacia solutions which is said to result in as much as a 50% improvement in the solubility of the product due not only to the concentration of acacia but also the amount of amorphous material in the spray-dried products. The dissolution rate of the spray-dried product is also reported to be almost instantaneous being about 60 times faster than that of the original powder. This is said to be due to a great improvement in the wettability of the spray-dried material. However, for certain crystalline active ingredients, improved dissolution kinetics may not be sufficiently improved by an increase in wettability.
WO-A-2008/006712 (Unilever) discloses a process for making contra-soluble nano-dispersions of at most sparingly-soluble materials in a soluble carrier material comprising the steps of:
(i) providing a single phase mixture of : (a) a solvent or a mixture of miscible solvents, (b) at least one carrier material soluble in solvent (a), said carrier material being also contra- soluble to payload material (c) and solid at ambient temperature, (c) at least one payload material which is soluble in solvent (a) , and,
(ii) drying the mixture to remove solvent (a) and thereby obtain the carrier material (b) in solid form with payload (c) dispersed therein as nanoparticles. Drying is typically performed by spray-drying.
Nevertheless, there remains a strong need to provide a simple process for improving dissolution kinetics.
The present invention seeks to address one or more of the abovementioned problems and/or to provide one or more of the abovementioned benefits.
Summary of the Invention
Accordingly, the present invention provides a process for preparing a spray- dried product for improving the rate of dissolution of the active ingredient, the process comprising the steps of:
(i) mixing a crystalline active ingredient, which has a dissolution rate in unstirred water at 25°C of greater than 15 minutes at a concentration of 14 ppm of the active ingredient, with a starch derivative, a second carrier material, and optionally xanthan gum to form a suspension, dispersion or solution of the active ingredient,
η
(ii) homogenizing the mixture at a pressure of at least 4000 psig (2.758 x 10 Pa), and
(iii) spray-drying the homogenized mixture,
the spray-dried active ingredient having an increased dissolution rate in water compared to the unencapsulated active ingredient. The invention further provides spray dried particles prepared according to the above mentioned process.
Detailed Description of the Invention
The present invention relates to a process by which the dissolution kinetics of a crystalline active ingredient can be significantly improved.
The invention is based on the combination of certain components, such as compounds or ingredients, together with defined processing conditions.
The first critical component is a starch derivative. By "starch derivative", it is meant a chemically modified starch, more preferably a hydrophobically modified starch, even more preferably an alkenyl-succinated starch.
The alkenyl-succinated starch preferably has a degree of substitution of from 0.001 to 0.9. The degree of substitution denotes the number of alkenylsuccinic functional groups per glucose units. Thus, a degree of substitution of 0.001 means that there is 1 alkenylsuccinic functional group per 1000 glucose units. The degree of substitution is more preferably from 0.005 to 0.3 and most preferably from 0.01 to 0.1, e.g. from 0.015 to 0.05.
The alkenyl-succinated starch is preferably a C3 to C14 alkenyl-succinated starch, more preferably C4 to C12, most preferably C5 to CIO, e.g. C7 to C9.
Most preferably the alkenyl-succinated starch is octenyl-succinated starch. Ideally the octenyl-succinated starch has a degree of substitution no greater than 0.03, more preferably no greater than 0.02.
The dissolution kinetics of the spray dried active ingredient are found to be significantly improved when the starch derivative is present in an amount of from 7% to 25% by weight, more preferably from 7 to 20%, based on the total weight of the mixture prior to spray-drying. At a level of less than 7%, the dissolution rate of the spray-dried active ingredient is hardly improved. Whereas, in an amount greater than 25%, the rate of dissolution is severely adversely affected. Without wishing to be bound by theory, it is believed that the reduction in the rate of dissolution is due to the insolubility of an excess of the starch derivative in water.
Another critical component is the second carrier material. The second carrier material is preferably a carbohydrate. For example, the second carrier material may comprise monosaccharides, disaccharides, trisaccharides, oligosaccharides, polysaccharides or mixtures thereof.
Suitable monosaccharides include: D-Apiose, L-Arabinose, 2-Deoxy-D-ribose, D-Lyxose, 2-O-Methyl-D-xylose, D-Ribose, D-Xylose, which are all pentoses; and Hexoses, such as for instance, L-Fructose, L-galactose, D-Galactose, D-Glucose, D-Mannose, L-Rhamnose, L-Mannose; and mixture of two or more of these.
Mono- and dissacharides may be reduced to the corresponding alcohols, such as for example, xylitol, sorbitol, D-mannitol and/or maltitol. Similarly, oxidation to aldonic, dicaroxyclic acids or uronic acids and reactions with acids, alkalis or amino compounds can give rise to many other compounds like isomaltol, for instance, which may comprise the second carrier material of the present invention.
Suitable oligosaccharides are molecules consisting of from 3 to 10 monosaccharide units, such as maltopentaose, fructo- and/or galacto-oligosaccharides.
Preferably, the second carrier material comprises a maltodextrin, most preferably having a mean dextrose equivalence of 5 to 25, preferably 6 to 20, more preferably 10 to 19.
In a preferred embodiment, the second carrier material is present in an amount of from 40 to 80%, more preferably 60 to 80% by weight, based on the total weight of the mixture prior to spray-drying.
An optional though preferred component is xanthan gum. Xanthan gum is a polysaccharide used as a food additive and rheology modifier. It is produced by fermentation of glucose or sucrose by the Xanthomonas campestris bacterium.
Xanthan gum is preferably added as a processing aid in order to maintain the insoluble crystalline solid suspended in solution prior to spray drying.
The optimum use level for maintaining an adequate suspension was found to be when the xanthan gum is present in an amount of from 0.3% to 0.6% by weight, based on the total weight of the mixture prior to spray-drying. In amounts inferior to 0.3%, it is a noticeable problem that the insoluble solids do not remain suspended in the slurry. Whereas, in amounts superior to 0.6%, the viscosity of the slurry is too high and this can adversely affect the homogenization step.
The active ingredient that is encapsulated is a compound that preferably has a dissolution rate in unstirred water at 25°C of more than 15 minutes at a concentration of 14 ppm. For the purposes of the present invention, "dissolution rate" is measured according to the method set out in the examples, described below.
The active ingredient is crystalline. By "crystalline" it is meant that the active ingredient forms a structure that exhibits long-range order in three dimensions. Crystallinity can be measured using known techniques in the art such as powder x-ray diffraction (PXRD) crystallography, solid state NMR, or thermal techniques such as differential scanning calorimetry (DSC).
The active ingredient may also be a "sparingly water-soluble organic active agent" . Such an ingredient is typically a compound that has a solubility in water of less than 5% by weight, preferably less than 1% by weight, more preferably less than 0.1% by weight, even more preferably less than 0.01% by weight, in water at 20°C.
Suitable active ingredients include those for use in the foodstuff, pharmaceutical and cosmetic applications. A non-limiting list of examples includes: flavour and fragrance materials of both natural and synthetic origins, compounds and mixtures such as heliotropine, bromelia, (5RS,6RS)-2,6,10,10-tetramethyl-l-oxaspiro-[4,5]dec-6-yl acetate, acetanisole, methylsalicylique aldehyde, para-ethyl phenol, phenol, phenylethyl salicylate, menthol, cyclohexanecarboxamide, veratraldehyde, xylenol, dodecanoic acid, thymol, heliotropyl acetate, methyl anisate, methylnaphtylketone, myristic acid, palmitic acid, dimethylphenol, dimethyl acrylic acid, coumarine, methyl cyclopentenolone, 7-methylcoumarin, phenylacetate, acetylpyrazine, phenylacetic acid, isoeugenyl acetate, raspberry ketone, naringin, propenyl guaethol, tetramethylpyrazine, acetylmethyl carbinol, 3-hydroxy-2-ethyl-4-pyranone, malic acid, resorcinol, benzoic acid, cinnamic acid, benjoin Sumatra, benjoin siam, citric acid, tartric acid, camphor, quinine chlorohydrate, ascorbic acid, borneol, glutamic acid, 5-methyl quinoxaline and malt extract; liposoluble vitamins, such as vitamin A and derivatives, vitamin D2, vitamin D3, natural or synthetic α-, β-, γ- or δ-tocopherol, preferably natural or synthetic a- tocopherol, and tocotrienol and tocopheryl Ci-C20-carboxylates; water-insoluble or sparingly water- soluble organic UV screening substances, such as, e.g., compounds from the group of the triazines, anilides, benzophenones, triazoles, cinnamides and sulfonated benzimidazoles; polyunsaturated fatty acids, such as, e.g., arachidonic acid, eicosapentaenoic acid or docosahexaenoic acid; food colorants, such as curcumine, carmine or chlorophyll; carotenoids, such as, e.g., β-carotene and lycopene; and xanthophylls, such as, e.g. lutein, astaxanthin, zeaxanthin, capsanthin, capsorubin, cryptoxanthin, citranaxanthin, canthaxanthin, bixin, P-apo-4-carotenal, P-apo-8-carotenal and P-apo-8-carotenic acid ethyl ester. The technical field of application is not critical though.
The active ingredient is preferably present in an amount of from 15 to 25% by weight, based on the total weight of the spray dried particle.
A suitable process for producing the spray-dried particles of the invention comprises a first step of forming a dispersion, suspension or solution of the starch and second carrier material. This may be performed by simple mixing of the components with water, preferably hot water at a temperature of 60°C to 80°C. Separately, a dispersion or solution is prepared of the active ingredient in a suitable solvent, such as propylene glycol. The two solutions are then mixed together.
The resulting mixture is homogenized according to defined processing parameters in order to provide a product having excellent dissolution kinetics.
Critically, the spray dried particles are prepared by a process in which a homogenization step occurs at a minimum pressure of 4000 psig, more preferably 5000 psig or more, most preferably 5500 psig or more prior to the spray drying step.
The homogenization step is preferably carried out in two or more complete passes in a standard homogenizer. A two-stage homogenizer is suitable for this purpose.
After homogenization, the mixture is subjected to a spray-drying step. The spray drying is preferably performed using nozzle atomization only. The spray pressure is preferably from about 1500 to 2500 psig. The inlet temperature is preferably from 180°C to 200°C. The outlet temperature is preferably from 70°C to 100°C.
The spray dried particles can then be collected by any standard process. Optionally and preferably they are passed through a sieve, such as a 20 Mesh screen to obtain a more homogeneous particle size.
The spray dried particles provide a significantly improved dissolution rate in a
0.05% aqueous citric acid solution of the active ingredient compared to the dissolution rate of the unencapsulated active ingredient. Further, most of the spray dried particles have an improved dissolution rate in water of the active ingredient compared to the dissolution rate of the unencapsulated active ingredient.
For instance, the dissolution rate in a 0.05% aqueous citric acid solution of the spray dried particles at 25°C is preferably less than 15 minutes at a concentration of 14 ppm of the active ingredient, more preferably less than 10 minutes, even more preferably less than 4 minutes, most preferably less than 2 minutes.
Examples
The invention will now be described with reference to the following examples. It is to be understood that the examples are illustrative of the invention and that the scope of the invention is not limited thereto.
Samples according to the invention are denoted by a number and comparative examples by a letter.
In the examples, and more generally for the purposes of the present invention, calculation of the dissolution kinetics of the spray-dried active ingredient are performed as follows.
Detection was made using a fiber optic spectrometer, comprising a D2Lite deuterium tungsten light source, TR 600-10 transmission probes (10mm pathlength tip) and a S2000 spectrometer (World Precision Instruments/ Ocean Optics). Data was recorded using the Ocean Optics software OOIBase32. Acquisition rate was set at one measurement per second.
The spectrum of the fully dissolved active was initially determined in the appropriate solvent (water or citric acid aq.) to find an appropriate wavelength for measurements. An amount of the spray dried powder was used for each experiment resulting in an equivalent nominal concentration of 14ppm of the active ingredient. The ax at 324 nm was chosen as the signal wavelength. A second wavelength (400 nm) where no absorption by the active ingredient was detected was used to correct the signal for changes in baseline caused by particles, turbidity, etc.
The spray dried powders were weighed on a weighing paper and rapidly tipped into the dissolution vessel (Distek 2100B, 1 liter flask maintained at 25°C using a water- bath) containing deionized water as the solvent for one set of experiments, and 500 ppm citric acid in deionized water for a second set of experiments. The contents were stirred using paddles at 200 rpm. Experiments were run until there was no longer a noticeable increase in absorbance on a plot of absorbance versus log time. The results were normalized by dividing the absorbance at each data point with the maximum absorbance. The kinetics of dissolution were quantified by finding the time at which the normalized absorbance reached 0.95. These values are equivalent to the dissolution of 95% of the active ingredient.
The same method was used for calculating the dissolution rate of the active ingredient alone.
Example 1
Preparation of Spray-Dried Particles
The compositions given in table 1 were prepared as follows. The xanthan gum, maltodextrin and starch were added to the water that had been preheated to 70°C, and mixed until fully dissolved. Separately, the active ingredient was added to the propylene glycol solution and mixed for 30 minutes. The two mixtures were then combined and mixing was continued for a further 30 minutes.
The mixture was then transferred to a high pressure homogenizer and homogenization was carried out in two passes at the pressures given in the following table. The homogenized product was then spray dried under standard conditions at an inlet temperature of 171°C and an outlet temperature of 82°C. The resulting spray-dried particles were collected as a yellow powder. All amounts are parts by weight.
Table 1
Figure imgf000009_0001
(1) Propylene glycol
(2) ex Firmenich, ref. 946867 (3) Glucidex 19D, ex Roquette Freres
(4) Poorly soluble crystalline taste-modifying active ingredient, ex Firmenich ref. 983950
(5) Capsul, ex National Starch The samples were then dissolved in water or an aqueous citric acid solution, as described above to provide a solution containing 14 ppm of the active ingredient.
Table 2
Figure imgf000010_0001
The rate of dissolution of the various samples was then evaluated according to the methodology described above. The results for 95% dissolution are given in the following tables:
Table 3
In water (sec)
Sample
trial 1 trial 2 trial 3 trial 4 average
1 925 853 - - 889
2 749 665 - - 707
3 573 599 - - 586
4 479 556 - - 518
5 1162 1300 - - 1231
6 721 818 802 622 741 7 762 1310 - - 1036
8 1334 1184 1148 1215 1220
9 2071 2188 - - 2130
Table 4
In 0.05% citric acid aqueous solution (sec)
Sample
trial 1 trial 2 trial 3 trial 4 average
1 230 - - - 230
2 228 - - - 228
3 78 - - - 78
4 113 - - - 113
5 154 - - - 154
6 113 165 130 - 136
7 111 - - - 111
8 193 144 228 311 219
9 220 323 - - 272
The active ingredient alone had a dissolution rate of 1106 seconds in water at 25 C and of 437 seconds in 0.05% aqueous citric acid solution. Thus, the spray dried systems comprising the active ingredient show a remarkable improvement in dissolution kinetics in all cases when the spray dried active ingredient was dissolved in a dilute aqueous citric acid solution and in most cases where the spray dried active ingredient was dissolved in water.

Claims

Claims
1. A process for preparing a spray-dried product for improving the rate of dissolution of the active ingredient, the process comprising the steps of:
(i) mixing a crystalline active ingredient, which has a dissolution rate in unstirred water at 25°C of greater than 15 minutes at a concentration of 14ppm of the active ingredient, with a starch derivative, a second carrier material, and optionally xanthan gum to form a suspension, dispersion or solution of the active ingredient,
η (ii) homogenizing the mixture at a pressure of at least 4000 psig (2.758 x 10 Pa), and (iii) spray-drying the homogenized mixture,
the spray-dried active ingredient having an increased dissolution rate in water compared to the unencapsulated active ingredient.
2. A process according to claim 1 , wherein the starch derivative is present in an amount of from 7 to 25% by weight, based on the total weight of the spray dried particle.
3. A process according to claim 1, wherein the amount of xanthan gum is from 0.3 to 0.6% by weight, based on the total weight of the mixture prior to spray- drying.
4. A process according to claim 1 , wherein the active ingredient is present in an amount of from 3% to 25% by weight, based on the total weight of the mixture prior to spray-drying.
5. A process according to claim 1, wherein the homogenization step is performed in two or more passes through a homogenizer.
6. A process according to claim 1 , wherein the starch derivative comprises an alkenyl-succinated starch, preferably an octenyl-succinated starch. Ideally the octenyl- succinated starch has a degree of substitution no greater than 0.03, more preferably no greater than 0.02.
7. A process according to claim 6, wherein the alkenyl-succinated starch is an octenyl-succinated starch.
8. A process according to claim 7, wherein the octenyl-succinated starch has a degree of substitution no greater than 0.03.
9. A process according to claim 1, wherein the second carrier material comprises a maltodextrin having a mean dextrose equivalence of 5 to 25.
10. A process according to claim 1 wherein the homogenization step (ii) occurs in two complete passes.
11. A process according to claim 1 wherein the starch derivative is present in an amount of from 7 to 25% by weight, based on the total weight of the mixture prior to spray-drying.
12. A process according to claim 1 wherein the second carrier material is present in an amount of from 60 to 80% by weight, based on the total weight of the mixture prior to spray-drying.
13. A spray dried particle prepared according to the process of claim 1.
PCT/IB2011/051294 2010-03-28 2011-03-28 Spray-dried crystalline active ingredient WO2011121515A1 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
BR112012024464-7A BR112012024464B1 (en) 2010-03-28 2011-03-28 PROCESS TO PREPARE A SPRAY DRY PRODUCT USING MALTODEXTRIN, XANTHAN GUM AND STARCH DERIVATIVES TO IMPROVE THE DISSOLUTION RATE OF THE ACTIVE INGREDIENT
JP2013502007A JP5602936B2 (en) 2010-03-29 2011-03-28 Spray-dried crystalline active ingredient
EP11716063.0A EP2552234B1 (en) 2010-03-29 2011-03-28 Spray-dried crystalline active ingredient
MX2012010555A MX2012010555A (en) 2010-03-29 2011-03-28 Spray-dried crystalline active ingredient.
RU2012145868/13A RU2539855C2 (en) 2010-03-29 2011-03-28 Crystalline active ingredient dried with spray drying
US13/637,214 US20130028976A1 (en) 2010-03-29 2011-03-28 Spray-dried crystalline active ingredient
CN2011800146455A CN102802436A (en) 2010-03-29 2011-03-28 Spray-dried crystalline active ingredient

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31852910P 2010-03-29 2010-03-29
US61/318,529 2010-03-29

Publications (1)

Publication Number Publication Date
WO2011121515A1 true WO2011121515A1 (en) 2011-10-06

Family

ID=44141036

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2011/051294 WO2011121515A1 (en) 2010-03-28 2011-03-28 Spray-dried crystalline active ingredient

Country Status (8)

Country Link
US (1) US20130028976A1 (en)
EP (1) EP2552234B1 (en)
JP (1) JP5602936B2 (en)
CN (2) CN106974316B (en)
BR (1) BR112012024464B1 (en)
MX (1) MX2012010555A (en)
RU (1) RU2539855C2 (en)
WO (1) WO2011121515A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2013183422A1 (en) * 2012-06-08 2016-01-28 理研ビタミン株式会社 Stearoyl sodium lactate preparation
WO2017080625A1 (en) * 2015-11-15 2017-05-18 Symrise Ag Reduction of stinging sensation on skin

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109601999A (en) * 2018-11-01 2019-04-12 华南农业大学 A kind of lycopene nanometer powder and preparation method thereof
CN114642601A (en) * 2022-02-17 2022-06-21 广东丸美生物技术股份有限公司 Anti-aging blue light-resisting and wrinkle-removing composition and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999052526A1 (en) * 1998-04-09 1999-10-21 Roche Diagnostics Gmbh Carvedilol-galenics
WO2005055964A1 (en) * 2003-12-08 2005-06-23 Salvona Llc Moisture triggered sealed release system
WO2008006712A2 (en) 2006-07-13 2008-01-17 Unilever Plc Preparation of nanodispersions
US20090252789A1 (en) * 2006-05-19 2009-10-08 Gil Trophardy One step spray-drying process

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9901819D0 (en) * 1999-01-27 1999-03-17 Scherer Corp R P Pharmaceutical compositions
JP4338945B2 (en) * 2002-06-28 2009-10-07 松谷化学工業株式会社 Water-soluble polymer with improved solubility
US7488503B1 (en) * 2003-03-31 2009-02-10 Mccormick & Company, Inc. Encapsulation compositions and processes for preparing the same
CA2550533C (en) * 2004-02-19 2011-04-12 Helena Vanhoutte Spray-dried starch hydrolysate agglomerate product and method for preparing a spray-dried starch hydrolysate agglomerate product
EP1782803B1 (en) * 2004-08-24 2015-06-03 Nisshin Pharma Inc. Coenzyme q10-containing composition
JP2006320311A (en) * 2005-04-19 2006-11-30 Nisshin Pharma Inc Food containing coenzyme q10 and minerals and method for producing the same
JP5129130B2 (en) * 2005-06-29 2013-01-23 ディーエスエム アイピー アセッツ ビー．ブイ． Topical composition comprising nanoparticles of isoflavones
WO2007080787A1 (en) * 2006-01-12 2007-07-19 Nisshin Pharma Inc. Coenzyme q10-containing water-soluble compositions
CN101204221B (en) * 2006-12-19 2011-12-07 张雨生 Sugar free health care grosvenori crystal and manufacture method thereof
CN100506282C (en) * 2007-02-12 2009-07-01 清华大学 Linseed oil microcapsule powder and preparation method thereof
EP2217094A1 (en) * 2007-12-05 2010-08-18 DSM IP Assets B.V. Pulverous formulation of a fat-soluble active ingredient
CN101439029A (en) * 2008-12-19 2009-05-27 江南大学 Method for preparing micro-encapsulated astaxanthin using pure glue gum as wall material
PL2470606T3 (en) * 2009-08-28 2014-04-30 Chr Hansen Natural Colors As High strength carbo substances

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999052526A1 (en) * 1998-04-09 1999-10-21 Roche Diagnostics Gmbh Carvedilol-galenics
WO2005055964A1 (en) * 2003-12-08 2005-06-23 Salvona Llc Moisture triggered sealed release system
US20090252789A1 (en) * 2006-05-19 2009-10-08 Gil Trophardy One step spray-drying process
WO2008006712A2 (en) 2006-07-13 2008-01-17 Unilever Plc Preparation of nanodispersions

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KAWASHIMA Y, SAITO M, TAKENAKA H: "Improvement of solubility and dissolution rate of poorly water-soluble salicylic acid by a spray-drying technique", J. PHARM. PHARMACOL., vol. 27, 1975, pages 1 - 5
PINNAMANENI S., DAS N.G., DAS S.K.: "Formulation approaches for orally administered poorly soluble drugs", PHARMAZIE, vol. 57, 2002, pages 291 - 300, XP001115790

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2013183422A1 (en) * 2012-06-08 2016-01-28 理研ビタミン株式会社 Stearoyl sodium lactate preparation
WO2017080625A1 (en) * 2015-11-15 2017-05-18 Symrise Ag Reduction of stinging sensation on skin
CN108472220A (en) * 2015-11-15 2018-08-31 西姆莱斯股份公司 Reduce skin irritation impression
JP2018533609A (en) * 2015-11-15 2018-11-15 シムライズ アーゲー Reduction of skin ache
CN108472220B (en) * 2015-11-15 2022-06-17 西姆莱斯股份公司 Reducing the perception of skin stinging

Also Published As

Publication number Publication date
US20130028976A1 (en) 2013-01-31
RU2539855C2 (en) 2015-01-27
BR112012024464A2 (en) 2015-09-15
CN106974316A (en) 2017-07-25
RU2012145868A (en) 2014-05-10
JP5602936B2 (en) 2014-10-08
EP2552234A1 (en) 2013-02-06
BR112012024464B1 (en) 2021-08-03
JP2013529062A (en) 2013-07-18
CN106974316B (en) 2019-07-19
CN102802436A (en) 2012-11-28
MX2012010555A (en) 2012-10-05
EP2552234B1 (en) 2013-12-04

Similar Documents

Publication Publication Date Title
Robert et al. Acetylated starch and inulin as encapsulating agents of gallic acid and their release behaviour in a hydrophilic system
JP5743941B2 (en) Carotenoid-containing composition and method for producing the same
US20100034956A1 (en) Highly Water Dispersible Powder and Production Method Thereof
Yousefi et al. Developing spray-dried powders containing anthocyanins of black raspberry juice encapsulated based on fenugreek gum
EP2676553B1 (en) Carotenoid-containing composition
TWI531321B (en) Composition containing fat-soluble vitamin
Semalty et al. Preparation and characterization of cyclodextrin inclusion complex of naringenin and critical comparison with phospholipid complexation for improving solubility and dissolution
US20130028976A1 (en) Spray-dried crystalline active ingredient
US9993010B2 (en) Carotenoid-containing composition and method for producing same
CN110200910B (en) Preparation method of coenzyme Q10 transparent aqueous dispersion
JPWO2014112573A1 (en) Fucoxanthin-containing composition and method for producing the same
Ding et al. Characterisation of spray dried microencapsules with amorphous lutein nanoparticles: Enhancement of processability, dissolution rate, and storage stability
Vázquez-González et al. Electrosprayed cashew gum microparticles for the encapsulation of highly sensitive bioactive materials
Ruengdech et al. Improving encapsulating efficiency, stability, and antioxidant activity of catechin nanoemulsion using foam mat freeze-drying: The effect of wall material types and concentrations
Wang et al. Stability of lutein in O/W emulsion prepared using xanthan and propylene glycol alginate
JPWO2005026213A1 (en) Method for producing modified gum arabic
Halahlah et al. Wood hemicelluloses as sustainable wall materials to protect bioactive compounds during spray drying of bilberries
Garcia et al. Microencapsulation of shark liver oil pool by spray drying
Laine et al. Comparison of microencapsulation properties of spruce galactoglucomannans and Arabic gum using a model hydrophobic core compound
JP5812856B2 (en) Solubility stabilizer for stilbene derivative, curcuminoid, pteridine derivative or purine derivative, composition containing the same, solubility stabilization method and use thereof
JP2023098403A (en) Composition, method for manufacturing the same, and surfactant
JP2017049149A (en) Quantification method of crocetin
JP2016067300A (en) Beverage composition and method of producing beverage composition
KR101478057B1 (en) Method for microcapsulating β-carotene using chitosan
Schex et al. Technical formulation of hydrophobic pigments

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201180014645.5

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11716063

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: MX/A/2012/010555

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 2011716063

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 13637214

Country of ref document: US

Ref document number: 2807/KOLNP/2012

Country of ref document: IN

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2013502007

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2012145868

Country of ref document: RU

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112012024464

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 112012024464

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20120926